Lynx Biosciences Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Investors
-
13
Lynx Biosciences General Information
Description
Operator of a biotechnology company intended to offer personalized cancer treatments to patients. The company combines physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates, enabling blood cancer patients and multiple myeloma patients to receive a response to clinical treatment.
Contact Information
Website
www.lynx.bioCorporate Office
- 3210 Merryfield Row
- San Diego, CA 92121-1126
- United States
Corporate Office
- 3210 Merryfield Row
- San Diego, CA 92121-1126
- United States
Lynx Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | 01-Feb-2026 | Completed | Generating Revenue | |||
| 10. Seed Round | 30-Aug-2024 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Seed Round | 03-Nov-2021 | Completed | Generating Revenue | |||
| 7. Grant | 24-Oct-2018 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 02-Apr-2018 | Completed | Generating Revenue | |||
| 5. Seed Round | 01-Jan-2018 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 3. Grant | 13-Oct-2016 | $419K | $5K | Completed | Startup | |
| 2. Accelerator/Incubator | 26-Sep-2016 | $5K | $5K | Completed | Startup |
Lynx Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 4,514,687 | $0.000100 | 6% | $0.44 | $0.44 | 1x | $0.44 | 26.9% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lynx Biosciences Comparisons
Industry
Financing
Details
Lynx Biosciences Competitors (4)
One of Lynx Biosciences’s 4 competitors is BioXcel, a Corporation company based in Branford, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioXcel | Corporation | Branford, CT | ||||
| Partex.AI | Venture Capital-Backed | Eschborn, Germany | ||||
| insitro | Venture Capital-Backed | South San Francisco, CA | ||||
| Recursion Pharmaceuticals | Formerly VC-backed | Salt Lake City, UT |
Lynx Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lynx Biosciences Patents
Lynx Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150087006-A1 | Cellular cis-co-culture systems and methods | Active | 20-Sep-2013 | ||
| US-9958432-B2 | Cellular cis-co-culture systems for analysis | Active | 20-Sep-2013 |
Lynx Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lynx Biosciences Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Phase Two Ventures | Venture Capital | Minority | ||
| Venture Twelve | Venture Capital | Minority | ||
| Wisconsin Alumni Research Foundation (Madison) | Limited Partner | Minority | ||
| Checkmate Capital | Venture Capital | Minority | ||
| Cove Fund | Venture Capital | Minority |
Lynx Biosciences FAQs
-
When was Lynx Biosciences founded?
Lynx Biosciences was founded in 2013.
-
Where is Lynx Biosciences headquartered?
Lynx Biosciences is headquartered in San Diego, CA.
-
What is the size of Lynx Biosciences?
Lynx Biosciences has 12 total employees.
-
What industry is Lynx Biosciences in?
Lynx Biosciences’s primary industry is Drug Discovery.
-
Is Lynx Biosciences a private or public company?
Lynx Biosciences is a Private company.
-
What is Lynx Biosciences’s current revenue?
The current revenue for Lynx Biosciences is .
-
How much funding has Lynx Biosciences raised over time?
Lynx Biosciences has raised $4.15M.
-
Who are Lynx Biosciences’s investors?
Phase Two Ventures, Venture Twelve, Wisconsin Alumni Research Foundation (Madison), Checkmate Capital, and Cove Fund are 5 of 13 investors who have invested in Lynx Biosciences.
-
Who are Lynx Biosciences’s competitors?
BioXcel, Partex.AI, insitro, and Recursion Pharmaceuticals are competitors of Lynx Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
